Steidl Ulrich, Rosenbauer Frank, Verhaak Roel G W, Gu Xuesong, Ebralidze Alexander, Otu Hasan H, Klippel Steffen, Steidl Christian, Bruns Ingmar, Costa Daniel B, Wagner Katharina, Aivado Manuel, Kobbe Guido, Valk Peter J M, Passegué Emmanuelle, Libermann Towia A, Delwel Ruud, Tenen Daniel G
Harvard Institutes of Medicine, Harvard Medical School and Harvard Stem Cell Institute, Boston, Massachusetts 02115, USA.
Nat Genet. 2006 Nov;38(11):1269-77. doi: 10.1038/ng1898. Epub 2006 Oct 15.
Knockdown of the transcription factor PU.1 (encoded by Sfpi1) leads to acute myeloid leukemia (AML) in mice. We examined the transcriptome of preleukemic hematopoietic stem cells (HSCs) in which PU.1 was knocked down (referred to as 'PU.1-knockdown HSCs') to identify transcriptional changes preceding malignant transformation. Transcription factors c-Jun and JunB were among the top-downregulated targets. Restoration of c-Jun expression in preleukemic cells rescued the PU.1 knockdown-initiated myelomonocytic differentiation block. Lentiviral restoration of JunB at the leukemic stage led to loss of leukemic self-renewal capacity and prevented leukemia in NOD-SCID mice into which leukemic PU.1-knockdown cells were transplanted. Examination of human individuals with AML confirmed the correlation between PU.1 and JunB downregulation. These results delineate a transcriptional pattern that precedes leukemic transformation in PU.1-knockdown HSCs and demonstrate that decreased levels of c-Jun and JunB contribute to the development of PU.1 knockdown-induced AML by blocking differentiation and increasing self-renewal. Therefore, examination of disturbed gene expression in HSCs can identify genes whose dysregulation is essential for leukemic stem cell function and that are targets for therapeutic interventions.
转录因子PU.1(由Sfpi1编码)的敲低会导致小鼠患急性髓系白血病(AML)。我们检测了敲低PU.1的白血病前期造血干细胞(HSCs)(称为“PU.1敲低HSCs”)的转录组,以确定恶性转化之前的转录变化。转录因子c-Jun和JunB是下调程度最高的靶点之一。白血病前期细胞中c-Jun表达的恢复挽救了由PU.1敲低引发的髓单核细胞分化阻滞。在白血病阶段通过慢病毒恢复JunB导致白血病自我更新能力丧失,并预防了将白血病性PU.1敲低细胞移植到其中的NOD-SCID小鼠发生白血病。对AML患者个体的检测证实了PU.1和JunB下调之间的相关性。这些结果描绘了PU.1敲低HSCs白血病转化之前的转录模式,并证明c-Jun和JunB水平降低通过阻断分化和增加自我更新促进了PU.1敲低诱导的AML的发展。因此,检测HSCs中受干扰的基因表达可以识别那些失调对白血病干细胞功能至关重要且是治疗干预靶点的基因。